Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

Immunobiology

Volumn 215, Issue 8, 2010, Pages 598-605

  Rieder, Sadiye Amcaoglu ^a   Chauhan, Ashok ^a   Singh, Ugra ^a   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cannabinoids; Immune suppression

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 ARACHIDONOYLGLYCEROL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR ANTAGONIST; CANNABINOL; CANNABIS; CASPASE 3; CASPASE 8; CASPASE 9; CHEMOKINE; CYTOKINE; DELTA8 TETRAHYDROCANNABINOL; DEXANABINOL; DRONABINOL; ENDOCANNABINOID; INTERLEUKIN 1BETA CONVERTING ENZYME; RIMONABANT; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DIABETES MELLITUS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE SCLEROSIS; NAUSEA AND VOMITING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; ANIMAL; ANTIGEN PRESENTING CELL; DRUG EFFECT; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE; METABOLISM;

ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; CANNABINOIDS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTES; RECEPTOR, CANNABINOID, CB2;

EID: 77954175124     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.04.001     Document Type: Review

References (54)

1. Blazquez C., Carracedo A., Barrado L., Real P.J., Fernandez-Luna J.L., Velasco G., et al. Cannabinoid receptors as novel targets for the treatment of melanoma. Faseb J. 2006, 20(14):2633-2635.
2. Di Filippo C., Rossi F., Rossi S., D'Amico M. Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN. J. Leukoc. Biol. 2004, 75(3):453-459.
3. Cabral G.A., Mishkin E.M. Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators. J. Toxicol. Environ. Health 1989, 26(2):175-182.
4. Camacho I.A., Hassuneh M.R., Nagarkatti M., Nagarkatti P.S. Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin(TCDD)-induced immunotoxicity in peripheral T cells. Toxicology 2001, 165(1):51-63.
5. Chen Y., Buck J. Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J. Pharmacol. Exp. Ther. 2000, 293(3):807-812.
6. Condie R., Herring A., Koh W.S., Lee M., Kaminski N.E. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (il-2) expression in the murine t-cell line, el4.Il-2. J. Biol. Chem. 1996, 271(22):13175-13183.
7. Croxford J.L., Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?. J. Neuroimmunol. 2005, 166(1-2):3-18.
8. Derocq J.M., Segui M., Marchand J., Le Fur G., Casellas P. Cannabinoids enhance human b-cell growth at low nanomolar concentrations. FEBS Lett. 1995, 369(2-3):177-182.
9. Do Y., McKallip R.J., Nagarkatti M., Nagarkatti P.S. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers nf-kappab-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J. Immunol. 2004, 173(4):2373-2382.
10. El-Gohary M., Eid M.A. Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students. Hum. Exp. Toxicol. 2004, 23(3):149-156.
11. George K.L., Saltman L.H., Stein G.S., Lian J.B., Zurier R.B. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. J. Cell Physiol. 2008, 214(3):714-720.
12. Guzman M. Cannabinoids: potential anticancer agents. Nat. Rev. Cancer 2003, 3(10):745-755.
13. Guzman M., Sanchez C., Galve-Roperh I. Cannabinoids and cell fate. Pharmacol. Ther. 2002, 95(2):175-184.
14. Hampson A.J., Grimaldi M., Axelrod J., Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. USA 1998, 95(14):8268-8273.
15. Hegde V.L., Hegde S., Cravatt B.F., Hofseth L.J., Nagarkatti M., Nagarkatti P.S. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: Involvement of regulatory t cells. Mol. Pharmacol. 2008, 74(1):20-33.
16. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407(6805):770-776.
17. Herrera B., Carracedo A., Diez-Zaera M., Gomez del Pulgar T., Guzman M., Velasco G. The cb2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. Exp. Cell Res. 2006, 312(11):2121-2131.
18. Igney F.H., Krammer P.H. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2002, 2(4):277-288.
19. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J. Clin. 2002, 52(2):72-91.
20. Jia W., Hegde V.L., Singh N.P., Sisco D., Grant S., Nagarkatti M., et al. Delta9-tetrahydrocannabinol-induced apoptosis in jurkat leukemia t cells is regulated by translocation of bad to mitochondria. Mol. Cancer Res. 2006, 4(8):549-562.
21. Kamath A.B., Nagarkatti P.S., Nagarkatti M. Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo (1997). Toxicol. Appl. Pharmacol. 1997, 142(2):367-377.
22. Karst M., Salim K., Burstein S., Conrad I., Hoy L., Schneider U. Analgesic effect of the synthetic cannabinoid ct-3 on chronic neuropathic pain: a randomized controlled trial. J. Am. Med. Assoc. 2003, 290(13):1757-1762.
23. Klein T.W., Newton C.A., Friedman H. Cannabinoid receptors and immunity. Immunol. Today 1998, 19(8):373-381.
24. Klein T.W., Lane B., Newton C.A., Friedman H. The cannabinoid system and cytokine network. Proc. Soc. Exp. Biol. Med. 2000, 225(1):1-8.
25. Klein T.W., Cabral G.A. Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J. Neuroimmune Pharmacol. 2006, 1(1):50-64.
26. Klein T.W., Newton C., Zhu W., Daaka Y., Friedman H. Delta 9-tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila. Proc. Soc. Exp. Biol. Med. 1995, 209(3):205-212.
27. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 2000, 6(5):513-519.
28. Lee C.Y., Wey S.P., Liao M.H., Hsu W.L., Wu H.Y., Jan T.R. A comparative study on cannabidiol-induced apoptosis in murine thymocytes and el-4 thymoma cells. Int. Immunopharmacol. 2008, 8(5):732-740.
29. Lee S.F., Newton C., Widen R., Friedman H., Klein T.W. Differential expression of cannabinoid cb(2) receptor mrna in mouse immune cell subpopulations and following b cell stimulation. Eur. J. Pharmacol. 2001, 423(2-3):235-241.
30. Lombard C., Nagarkatti M., Nagarkatti P. Cb2 cannabinoid receptor agonist, jwh-015, triggers apoptosis in immune cells: Potential role for cb2-selective ligands as immunosuppressive agents. Clin. Immunol. 2007, 122(3):259-270.
31. Lombard C., Nagarkatti M., Nagarkatti P.S. Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in delta9-tetrahydrocannabinol (thc)-induced apoptosis of jurkat cells. Leuk. Res. 2005, 29(8):915-922.
32. Lopez-Cepero M., Friedman M., Klein T., Friedman H. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J. Leukoc. Biol. 1986, 39(6):679-686.
33. Lu T., Newton C., Perkins I., Friedman H., Klein T.W. Cannabinoid treatment suppresses the t-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection. J. Pharmacol. Exp. Ther. 2006, 319(1):269-276.
34. Maccarrone M., Lorenzon T., Bari M., Melino G., Finazzi-Agro A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem. 2000, 275(41):31938-31945.
35. Mackie K. Cannabinoid receptors as therapeutic targets. Annu. Rev. Pharmacol. Toxicol. 2006, 46:101-122.
36. McCoy K.L., Gainey D., Cabral G.A. Delta 9-tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther. 1995, 273(3):1216-1223.
37. McKallip R.J., Jia W., Schlomer J., Warren J.W., Nagarkatti P.S., Nagarkatti M. Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and nox4 expression. Mol. Pharmacol. 2006, 70(3):897-908.
38. McKallip R.J., Lombard C., Fisher M., Martin B.R., Ryu S., Grant S., et al. Targeting cb2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 2002, 100(2):627-634.
39. McKallip R.J., Lombard C., Martin B.R., Nagarkatti M., Nagarkatti P.S. Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. J. Pharmacol. Exp. Ther. 2002, 302(2):451-465.
40. McKallip R.J., Nagarkatti M., Nagarkatti P.S. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J. Immunol. 2005, 174(6):3281-3289.
41. Pollmann W., Fenenberg W. Current management associated with multiple sclerosis. CNS Drugs 2008, 22(4):291-324.
42. Rachelefsky G.S., Opelz G., Mickey M.R., Lessin P., Kiuchi M., Silverstein M.J., et al. Intact humoral and cell-mediated immunity in chronic marijuana smoking. J. Allergy Clin. Immunol. 1976, 58(4):483-490.
43. Rajesh M., Pan H., Mukhopadhyay P., Bátkai S., Osei-Hyiaman D., Haskó G., Liaudet L., Gao B., Pacher P. J. Leukoc. Biol. 2007, 82(6):1382-1389.
44. Schwarz H., Blanco F.J., Lotz M. Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J. Neuroimmunol. 1994, 55(1):107-115.
45. Singh N.P., Nagarkatti M., Nagarkatti P. Primary peripheral T cells become susceptible to 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in vitro upon activation and in the presence of dendritic cells. Mol. Pharmacol. 2008, 73(6):1722-1735.
46. Tashkin D.P., Baldwin GC., Sarafian T., Dubinett S., Roth M.D. Respiratory and immunologic consequences of marijuana smoking. J. Clin. Pharmacol. 2002, 42(11):71S-81S.
47. Tramer M.R., Carroll D., Campbell F.A., Reynolds D.J., Moore R.A., McQuay H.J. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. Br. Med. J. 2001, 323(7303):16-21.
48. Varga K., Wagner J.A., Bridgen D.T., Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. Faseb J. 1998, 12(11):1035-1044.
49. Wang Y., Liu Y., Ito Y., Hashiguchi T., Kitajima I., Yamakuchi M., et al. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin b-selective adsorption and subsequent high-performance liquid chromatography analysis: Increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal. Biochem. 2001, 294(1):73-82.
50. Yebra M., Klein T.W., Friedman H. Delta 9-tetrahydrocannabinol suppresses concanavalin A induced increase in cytoplasmic free calcium in mouse thymocytes. Life Sci. 1992, 51(2):151-160.
51. Zhu W., Friedman H., Klein T.W. Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of bcl-2 and caspase-1. J. Pharmacol. Exp. Ther. 1998, 286(2):1103-1109.
52. Zhu W., Igarashi T., Friedman H., Klein T.W. Delta 9-tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits. J Pharmacol. Exp. Ther. 1995, 274(2):1001-1007.
53. Zhu W., Newton C., Daaka Y., Friedman H., Klein T.W. Delta 9-tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages. J. Pharmacol. Exp. Ther. 1994, 270(3):1334-1339.
54. Zurier R.B., Rossetti R.G., Lane J.H., Goldberg J.M., Hunter S.A., Burstein S.H. Dimethylheptyl-thc-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure. Arthritis Rheum. 1998, 41(1):163-170.